Herpes Zoster Hospitalizations in Italy

Launched by UNIVERSITY OF L'AQUILA · Jul 11, 2023

Keywords

ClinConnect Summary

This clinical trial is focusing on understanding hospital admissions related to Herpes Zoster, commonly known as shingles, in Italy. The researchers want to gather more information about how often people are hospitalized for this condition, especially those who have other health issues that might weaken their immune system. They are also interested in exploring if there is any connection between Herpes Zoster and COVID-19 since some patients with COVID-19 have experienced shingles outbreaks.

To be part of this study, participants should be at least 18 years old and have been hospitalized for Herpes Zoster, either as their main diagnosis or as a secondary issue. The trial is currently recruiting individuals of all ages who meet these criteria. If you join the study, you can expect to help researchers gain valuable insights that could lead to better understanding and prevention of Herpes Zoster, which may encourage more people to get vaccinated and reduce hospitalizations.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Hospital discharge records for Herpes Zoster infection in primary diagnosis age ≥18 years
• • Hospital discharge records for Herpes Zoster infection in secondary diagnoses age ≥18 years
• Exclusion Criteria:
• • Hospital discharge records for Herpes Zoster infection in primary diagnosis age \<18 years
• • Hospital discharge records for Herpes Zoster infection in secondary diagnoses age \<18 years